The Economic Times
US fund Platinum acquires Inventia Health in India foray
Healthcare, Mumbai-based pharmaceuticals company, at a valuation of Rs 2,500 crore ($300 million), said multiple people aware of the development. India vs SA Final Pitch ReportExisting ...
20 minutes ago